We intend to focus on businesses in the technology metals (“Technology Metals”) and energy transition critical materials (“ETMs”) sectors and the geographic region of the company’s search for a prospective target will not include the People’s Republic of China (“China” or the “PRC”) or the special administrative regions of Hong Kong or Macau, and we […]

Although we intend to target North American or European companies, our focus will be to acquire a business in the healthcare industry in the United States. We believe the healthcare industry, particularly the life sciences sector, represents an enormous and growing target market with a large number of potential target acquisition opportunities. More specifically, we […]

We are a newly organized blank check company incorporated in March 2021. We seek to capitalize on the significant experience and contacts of our management team, led by Daniel J. O’Connor, in consummating an initial business combination. Although we may pursue an initial business combination opportunity in any business, industry, sector or geographical location, we intend to focus on […]

We intend to focus on targets in the TMT (telecom, media and technology) sector.  (**Note: About 10 qualified institutional buyers had each indicated an interest in buying up to 9.99 percent of the units in the IPO – or in aggregate up to 99.9 percent of the deal, the prospectus says.) (Note: Sagaliam Acquisition Corp. priced […]

We will search for target businesses involved in EV (electric vehicles) technology, smart mobility or sustainable transportation and related businesses in the Asia Pacific region, primarily Southeast Asia, where our management team has extensive experience in information technology, transportation operations and manufacturing industries. (Note: Arogo Capital Acquisition Corp. announced the pricing of its downsized SPAC […]

It is our intention to pursue prospective targets that are focused on healthcare innovation. We anticipate targeting what are traditionally known as “small cap” companies domiciled in North America, Europe and/or the Asia Pacific (“APAC”) regions that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space which aligns with our management team’s […]

(Note: This is an IPO of 6 million American Depositary Shares (ADS). Each ADS equals one ordinary share. Yoshitsu filed confidentially with the SEC for an IPO on Dec. 23, 2021, and filed its F-1 prospectus on Aug. 27, 2021. The company’s formal name is Yoshitsu Boueki Kabushiki Kaisha) Headquartered in Tokyo, we are a […]

Our objective is to identify and consummate a business combination with a business in the consumer, media and/or technology sectors that leverages D2C (Direct-to-Consumer) engagement as its primary go-to-market channel. We believe that the COVID-19 pandemic has increased consumers’ focus on health, wellness and fitness, while simultaneously accelerating consumers’ adoption of digital and mobile commerce […]

We are a leading global alternative asset manager with approximately $109 billion in assets under management as of Sept. 30, 2021. (The company is changing its name to TPG, Inc., from TPG Partners, LLC.) We have built our firm through a 30-year history of successful innovation and organic growth, and we believe that we have delivered attractive risk-adjusted […]

Our business strategy is to identify and complete our initial business combination with a company whose operations are in the de-carbonization / renewable energy sectors, with a particular focus in Japan /Asia (excluding China) and European markets. We will not complete our initial business combination with a target that is headquartered China (including Hong Kong […]